CAMBRIDGE, Mass.--(BUSINESS WIRE)--Omega Therapeutics™, a company pioneering a new category of genomic medicine through epigenomic programming, today announced the completion of an $85 million ...
Next-generation LumenX platform combines more power and pins to significantly expand LumenX device support library, future-proof customer investments and lower the cost of ownership for global ...
Integrated quantum computing company Quantinuum Ltd. today unveiled new open-source software tools designed to accelerate software development for quantum computing with a more intuitive programming ...
New LumenX2 programming platform engineered with more capabilities enables significant expansion of LumenX algorithm library future-proofing customers programming requirements “Semiconductor devices ...
The Science Advances publication details Cellgorithm™, a CRISPR-based technology that gives researchers greater control over gene activity and sets the stage for future applications in stem cell ...
Hello, I am writing a saved game editor for an old, old, old DOS game called X-Com:UFO Defense. I'll be writing it for TFTD too... but I digress... Actually, I've already written it a few times, and ...
Omega’s platform enables controllable and tunable epigenomic programming. It will provide patients and physicians with therapeutic alternatives to gene editing and gene therapy while offering the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback